NPI: 1457470858 · MEDWAY, MA 02053 · Physician Assistant · NPI assigned 03/28/2007
Authorized official PINCINCE, DEBORAH controls 20+ related entities in our dataset. Read more
| Authorized Official | PINCINCE, DEBORAH (ADMINISTRATOR) |
| NPI Enumeration Date | 03/28/2007 |
Other providers sharing the same authorized official: PINCINCE, DEBORAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 36,664 | $1.31M |
| 2019 | 34,131 | $1.21M |
| 2020 | 47,673 | $1.04M |
| 2021 | 195,132 | $4.26M |
| 2022 | 115,834 | $2.29M |
| 2023 | 78,662 | $1.34M |
| 2024 | 37,857 | $912K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 31,781 | 31,748 | $2.14M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 150,763 | 138,182 | $1.98M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38,054 | 36,396 | $1.80M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 60,750 | 56,829 | $1.68M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22,004 | 21,185 | $1.24M |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 17,297 | 17,247 | $836K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 24,297 | 22,346 | $544K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 21,487 | 21,157 | $379K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 11,487 | 10,956 | $333K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 21,080 | 20,787 | $239K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 15,527 | 8,585 | $193K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 6,778 | 6,674 | $121K |
| 90686 | 7,907 | 7,816 | $112K | |
| 90715 | 2,743 | 2,732 | $86K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1,061 | 1,060 | $74K |
| 90674 | 5,524 | 5,515 | $68K | |
| 90746 | 1,001 | 995 | $60K | |
| 91322 | 518 | 518 | $59K | |
| 99401 | 1,942 | 1,908 | $48K | |
| 91320 | 480 | 479 | $47K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,101 | 1,087 | $46K |
| 90480 | 1,070 | 1,067 | $36K | |
| 86580 | 3,902 | 3,745 | $24K | |
| 0004A | 470 | 465 | $19K | |
| 90682 | 654 | 651 | $18K | |
| 0082A | 362 | 360 | $16K | |
| 0064A | 427 | 416 | $16K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1,437 | 1,324 | $12K |
| 99201 | 436 | 436 | $12K | |
| 0134A | 320 | 278 | $12K | |
| 0124A | 271 | 247 | $11K | |
| 90750 | 227 | 227 | $10K | |
| 90707 | 296 | 294 | $10K | |
| 0081A | 190 | 187 | $8K | |
| 0001A | 173 | 172 | $8K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 252 | 252 | $7K |
| 0083A | 164 | 163 | $7K | |
| 0071A | 149 | 149 | $7K | |
| 90661 | 278 | 276 | $7K | |
| 0072A | 113 | 113 | $5K | |
| 90662 | 340 | 340 | $5K | |
| 90739 | 48 | 48 | $5K | |
| 81002 | 3,848 | 3,793 | $5K | |
| 0002A | 103 | 102 | $5K | |
| 90734 | 77 | 75 | $4K | |
| 90656 | 197 | 195 | $3K | |
| 0011A | 75 | 73 | $3K | |
| 99402 | 91 | 91 | $3K | |
| 90651 | 27 | 27 | $3K | |
| 0074A | 55 | 53 | $3K | |
| 90713 | 109 | 108 | $2K | |
| 0031A | 46 | 46 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 164 | 156 | $2K |
| 81025 | 428 | 426 | $2K | |
| 90673 | 25 | 25 | $1K | |
| 0154A | 30 | 28 | $1K | |
| 86308 | 230 | 229 | $1K | |
| 86328 | 29 | 29 | $912.00 | |
| 0012A | 16 | 16 | $688.17 | |
| G0008 | Administration of influenza virus vaccine | 196 | 196 | $624.84 |
| 0173A | 13 | 13 | $596.31 | |
| 90632 | 13 | 13 | $568.76 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 12 | 12 | $540.76 |
| 90694 | 45 | 45 | $483.00 | |
| 91321 | 12 | 12 | $130.56 | |
| 1036F | 18,104 | 17,135 | $64.03 | |
| 91312 | 218 | 194 | $0.02 | |
| 91300 | 96 | 89 | $0.01 | |
| 3077F | 450 | 444 | $0.00 | |
| 3078F | 12,627 | 12,261 | $0.00 | |
| 1160F | 12,927 | 12,327 | $0.00 | |
| 1159F | 11,668 | 11,194 | $0.00 | |
| 91313 | 261 | 219 | $0.00 | |
| 91308 | 450 | 439 | $0.00 | |
| 4124F | 59 | 59 | $0.00 | |
| 4120F | 12 | 12 | $0.00 | |
| 3079F | 4,116 | 4,048 | $0.00 | |
| 3074F | 14,900 | 14,400 | $0.00 | |
| 91301 | 35 | 31 | $0.00 | |
| 3008F | 7,195 | 6,992 | $0.00 | |
| 3075F | 1,562 | 1,543 | $0.00 | |
| 91317 | 13 | 13 | $0.00 | |
| 91307 | 87 | 82 | $0.00 | |
| 91315 | 27 | 25 | $0.00 | |
| 3080F | 144 | 143 | $0.00 |